The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Therapy-relevant gene signatures in the high risk localized renal cell carcinoma setting: Transcriptomic data from patients receiving placebo on a randomized phase III trial (PROTECT).

Phillip M.  Rappold

No Relationships to Disclose

Martin  Voss

Stock and Other Ownership Interests  - CellGenix (I)

Honoraria - Bristol-Myers Squibb

Consulting or Advisory Role - AVEO; Calithera Biosciences; Corvus Pharmaceuticals; Eisai; Exelixis; Merck; Pfizer

Research Funding - Pfizer

Travel, Accommodations, Expenses - AstraZeneca/MedImmune

Other Relationship - Bristol-Myers Squibb